These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 5672560)
21. Drug-induced extrapyramidal symptoms: their incidence and treatment. Sheppard C; Merlis S Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862 [No Abstract] [Full Text] [Related]
22. Incidence and significance of chlorpromazine-induced eye changes. De Long SL Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741 [No Abstract] [Full Text] [Related]
24. [Ocular manifestations during treatment with phenothiazine derivatives]. Ardouin M; Feuvrier YM; Delattre A Bull Soc Ophtalmol Fr; 1969 Mar; 69(3):395-401. PubMed ID: 5383905 [No Abstract] [Full Text] [Related]
25. Evaluation of butaperazine in chronic schizophrenia. Clark ML; Ray TS; Huber WK; Willis D; Ramsey HR Clin Pharmacol Ther; 1968; 9(6):757-64. PubMed ID: 4387043 [No Abstract] [Full Text] [Related]
26. [Ophthalmologic study of patients receiving psychotropic drugs]. Gol'dovskaia IL Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196 [No Abstract] [Full Text] [Related]
27. Quide vs. Mellaril in chronic schizophrenic patients. Gallant DM; Bishop MP Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558 [No Abstract] [Full Text] [Related]
28. Lens opacities and porphobilinogen-like substance in urine associated with levomepromazine. Kassman T; Wetterberg L Acta Psychiatr Scand; 1967; 43(2):163-8. PubMed ID: 6077783 [No Abstract] [Full Text] [Related]
29. Effects of prolonged phenothiazine intake on psychotic and other hospitalized children. McAndrew JB; Case Q; Treffert DA J Autism Child Schizophr; 1972; 2(1):75-91. PubMed ID: 5067403 [No Abstract] [Full Text] [Related]
30. Incidence of late "melanosis" side effects in chronic mental patients after long term phenothiazine therapy. Forrest FM; Snow HL; Erickson G; Geiter CW; Laxson GO Proc West Pharmacol Soc; 1966; 9():18-20. PubMed ID: 5958492 [No Abstract] [Full Text] [Related]
33. The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapy. Turunen S; Achté KA Psychiatr Q; 1967; 41(2):268-79. PubMed ID: 4383787 [No Abstract] [Full Text] [Related]
34. Sudden death in phenothiazine therapy. (A clinicopathologic study of 12 cases). Moore MT; Book MH Psychiatr Q; 1970; 44(3):389-402. PubMed ID: 5514886 [No Abstract] [Full Text] [Related]
35. Metabolic studies of chlorpromazine induced hyperpigmentation of the skin in psychiatric patients. Bolt AG; Forrest IS Agressologie; 1968; 9(2):201-7. PubMed ID: 5675487 [No Abstract] [Full Text] [Related]
36. [Eye and skin complications with long-term treatment of psychopharmaceutic agents]. Gunby B Nord Psykiatr Tidsskr; 1967; 21(5):378-88. PubMed ID: 5587721 [No Abstract] [Full Text] [Related]
37. [The neuroleptic syndrome. Attempted systematization of primary and secondary effects observed during neuroleptic treatments]. Lambert PA Encephale; 1971; 60(4):335-49. PubMed ID: 5004893 [No Abstract] [Full Text] [Related]
38. [Ultrastructural study of ocular pigmentation due to phenothiazines]. Sizaret P; Rossazza C; Brassart B Rev Otoneuroophtalmol; 1975; 47(4):247-51. PubMed ID: 1215727 [No Abstract] [Full Text] [Related]
39. Ocular changes occurring with prolonged high dose chlorpromazine therapy. Results from a collaborative study. Prien RF; DeLong SL; Cole JO; Levine J Arch Gen Psychiatry; 1970 Nov; 23(5):464-8. PubMed ID: 5478574 [No Abstract] [Full Text] [Related]
40. Phenothiazines and diabetes in hospitalized women. Thonnard-Neumann E Am J Psychiatry; 1968 Jan; 124(7):978-82. PubMed ID: 5634402 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]